Research ArticleClinical Investigations
Acute Thromboscintigraphy with 99mTc-Apcitide: Results of the Phase 3 Multicenter Clinical Trial Comparing 99mTc-Apcitide Scintigraphy with Contrast Venography for Imaging Acute DVT
Raymond Taillefer, Stephen Edell, Grant Innes and John Lister-James
Journal of Nuclear Medicine July 2000, 41 (7) 1214-1223;
Raymond Taillefer
Stephen Edell
Grant Innes
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Acute Thromboscintigraphy with 99mTc-Apcitide: Results of the Phase 3 Multicenter Clinical Trial Comparing 99mTc-Apcitide Scintigraphy with Contrast Venography for Imaging Acute DVT
Raymond Taillefer, Stephen Edell, Grant Innes, John Lister-James
Journal of Nuclear Medicine Jul 2000, 41 (7) 1214-1223;
Acute Thromboscintigraphy with 99mTc-Apcitide: Results of the Phase 3 Multicenter Clinical Trial Comparing 99mTc-Apcitide Scintigraphy with Contrast Venography for Imaging Acute DVT
Raymond Taillefer, Stephen Edell, Grant Innes, John Lister-James
Journal of Nuclear Medicine Jul 2000, 41 (7) 1214-1223;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Medicago Sativa Defensin 1 (MsDef1), A Natural Tumor Targeted Sensitizer for Improving Chemotherapy: Translation from Anti-Fungal Agent to Potential Anti-Cancer Agent
- Detection and Characterization of Thrombosis in Humans using Fibrin-Targeted Positron Emission Tomography and Magnetic Resonance
- Regarding "18F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi"